United Therapeutics UTHR Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's price / earnings?
- United Therapeutics (UTHR) reported price / earnings of 20.2× in Q1 2026.
- How has United Therapeutics's price / earnings changed year-over-year?
- United Therapeutics's price / earnings increased by 76.5% year-over-year, from 11.4× to 20.2×.
- What is the long-term trend for United Therapeutics's price / earnings?
- Over 4 years (2021 to 2025), United Therapeutics's price / earnings has grown at a -8.2% compound annual growth rate (CAGR), from 74.2× to 52.6×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.